PFS
INFI

Prospera Financial Services’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Prospera Financial Services’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed -$1K – 2740
2022
Q1 		$1K Buy
+1,000
New +$1.2K ﹤0.01% 2712

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Prospera Financial Services's INFI Position: Q2 2022 in Review

Prospera Financial Services sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 1,000 shares — an estimated $1K sold.

Prospera Financial Services first reported a position in INFI in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • Prospera Financial Services reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 1,000 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $1K.
  • Prospera Financial Services first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2022 and held it in 1 quarter.
  • Prospera Financial Services's Infinity Pharmaceuticals, Inc. position peaked at $1K in Q1 2022.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.